Submitted by Anonymous (not verified) on 23 July 2025 - 16:49
Human medicines European public assessment report (EPAR): Supemtek Tetra (previously Supemtek), quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 10, Status: Authorised
Source: